Sumary of Why rare blood clots could be a side effect of AstraZeneca COVID-19 vaccine:
- ‘Possible’ link between AstraZeneca vaccine and rare blood clots, EU drug regulator says The agency still recommends AstraZeneca for adults of all ages, but Britain has paused it for people under age 30..
- “These clots tend to occur in unusual areas, like the brain or the gut, and they also tend to be quite aggressive,”.
- The Hamilton hematologist and thrombosis medicine physician says the AstraZeneca vaccine appears to trigger antibodies directed against platelets, the sticky blood cells that form clots..
- “There was a very low rate of clotting cells (platelets) in some of the patients with these rare clotting complications, which would be a very unusual feature for some of your garden-variety clotting complications,”.
- The Vancouver stroke neurologist says typical risk factors for blood clots, including blood vessel damage, hormone replacement therapy and family history, don’t seem to play a role in this reaction..
- “It not the sort of thing that (doctors) are consistently seeing in people with a history of clots or necessarily other risk factors,”.
- Both doctors point out the risk of serious clots with COVID-19 is still much higher than the possible risk with AstraZeneca..
- While even typical blood clots affect one or two people in every 1,000, about one in 200 people with COVID-19 will develop clots..
- health expert Tim Caulfield – Mar 31, 2021 COVID-19 can cause inflammation in every organ of the body, and hospitalization means lying in bed for long periods of time, leading to blood pooling…